Arkolith/Insider Trading/SUPN/Form 4

Dec Timothy C

Senior Vice-President & CFOSUPERNUS PHARMACEUTICALS, INC. (SUPN) · full profile →Form 4 · filed Mar 10, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 6, 2026Tax withholding(F)1K$54.73$79K8K
Mar 6, 2026Option exercise(M)3K—$010K
Mar 6, 2026Tax withholding(F)1K$54.73$78K7K
Mar 6, 2026Option exercise(M)3K—$08K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 6, 2026Option exercise(M)3K—$00
Mar 6, 2026Option exercise(M)3K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001194020-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML